SCHEMBL4892282

SCHEMBL4892282

C1=CC2CC=C3CNCCC3C2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9118567 0.72
SCHEMBL2724026 0.67
Bromide SCHEMBL10911861 0.66
SCHEMBL29981430 0.65
SCHEMBL10508557 0.63
SCHEMBL7797825 0.61
SCHEMBL10741487 0.61
SCHEMBL7837564 0.60
SCHEMBL7418012 0.59
SCHEMBL7383342 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS PFIZER INC. 2008-12-18 US disclosed
US-5294618-A Psychological disorders MERCK SHARP & DOHME LIMITED (GB) 1994-03-15 US disclosed
US-5254561-A Tricyclic antipsychotic agents MERCK SHARP & DOHME LIMITED (GB) 1993-10-19 US disclosed
WO-1993008166-A1 BENZO-ISOQUINOLINE DERIVATIVES AND ANALOGS AND THEIR USE IN THERAPEUTICS THE UPJOHN COMPANY (US) 1993-04-29 WO disclosed
EP-0539209-A1 Benzo-isoquinoline derivatives and analogs and their use in therapeutics THE UPJOHN COMPANY (US) 1993-04-28 EP disclosed
EP-0463691-A2 Tricyclic sigma ligands MERCK SHARP &amp; DOHME LTD. (GB) 1992-01-02 EP disclosed
EP-0410535-A2 Octahydrobenzisoquinoline derivatives as antipsychotic agents MERCK SHARP & DOHME LTD. (GB) 1991-01-30 EP disclosed
EP-0106486-A2 Improvements in or relating to novel octahydrobenz(f)isoquinolines ELI LILLY AND COMPANY (US) 1984-04-25 EP disclosed
EP-0106486-A2 Improvements in or relating to novel octahydrobenz(f)isoquinolines ELI LILLY AND COMPANY (US) 1984-04-25 EP disclosed
EP-0106487-A2 Improvements in or relating to novel bridged hexahydrobenz(f)isoquinolines ELI LILLY AND COMPANY (US) 1984-04-25 EP disclosed
EP-0106486-A2 Improvements in or relating to novel octahydrobenz(f)isoquinolines ELI LILLY AND COMPANY (US) 1984-04-25 EP disclosed